NCT07139587 2025-09-10The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction AdenocarcinomaHebei General HospitalPhase NA Not yet recruiting30 enrolled